Search

everythinglearnresearchcommunity

for

Search:↓

Thujae occidentalis semen extract may help treat male pattern baldness by blocking a hair loss-related enzyme and reducing hair loss in mice.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

Nanoliposomes loaded with saw palmetto extract could be good for treating hair loss.

Padina arborescens and its component MOGG may help prevent hair loss through several actions, including blocking a hair loss-related enzyme.

Crinum asiaticum extract and norgalanthamine may promote hair growth by blocking an enzyme linked to hair loss and a pathway that stops hair growth.

A new treatment for hair loss shows promise with fewer side effects.

Higher levels of heat shock protein 27 and lower levels of miR-1 can increase AR levels, leading to hair loss in men.

Angiogenin may help treat hair loss by reducing certain proteins in hair cells.

Artemis dysfunction might cause hair loss through telomere shortening.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Topical finasteride may help treat facial hirsutism in women.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Both drugs lower DHT levels, with GI198745 being more effective.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.